• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双重触发,帕金森病小鼠模型的鼻腔诱导。

Double triggers, nasal induction of a Parkinson's disease mouse model.

作者信息

Song Guobin, Xi Guoping, Li Yanhua, Zhao Yijin, Qi Caixia, Song Lijuan, Xiao Baoguo, Ma Cungen

机构信息

Institute of Brain Science, Shanxi Key Laboratory of Inflammatory Neurodegenerative Diseases, Shanxi Datong University, Datong, 037009, China.

Research Center of Neurobiology, The Key Research Laboratory of Benefiting Qi for Acting Blood Circulation Method to Treat Multiple Sclerosis of State Administration of Traditional Chinese Medicine, Shanxi University of Chinese Medicine, Jinzhong, 030619, China.

出版信息

Neurosci Lett. 2020 Apr 17;724:134869. doi: 10.1016/j.neulet.2020.134869. Epub 2020 Feb 27.

DOI:10.1016/j.neulet.2020.134869
PMID:32114119
Abstract

Animal models of Parkinson's disease (PD), a chronic and progressive neurodegenerative disease of the central nervous system (CNS), play a key role in investigating the pathogenesis and developing new therapeutic strategies of PD. However, this goal has been limited by certain weaknesses in the available animal models of PD, e.g., induction by either pro-inflammatory or neurotoxic reagents, or they are too time-/effort-consuming. Here, we report a double triggers, nasal induction of a PD mouse model that mimics the clinical, pathological features and pathogenesis of PD by intranasal (i.n.) administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) combined with lipopolysaccharide (LPS). After administration once every three days for 7 consecutive weeks, these mice displayed enhanced motor dysfunction, loss of dopaminergic neurons, α-synuclein accumulation, as well as activation of microglia and astrocytes in the substantia nigra pars compacta compared with mice that were administered MPTP or LPS alone. This study provides a novel and basic research tool for investigating the pathogenesis and therapeutic intervention of PD.

摘要

帕金森病(PD)是一种慢性进行性中枢神经系统(CNS)神经退行性疾病,其动物模型在研究PD的发病机制和开发新的治疗策略中发挥着关键作用。然而,这一目标受到现有PD动物模型某些弱点的限制,例如由促炎或神经毒性试剂诱导,或者它们太耗时/费力。在此,我们报告一种双触发、经鼻腔诱导的PD小鼠模型,该模型通过经鼻(i.n.)给予1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)与脂多糖(LPS)联合使用,模拟了PD的临床、病理特征和发病机制。连续7周每3天给药一次后,与单独给予MPTP或LPS的小鼠相比,这些小鼠表现出增强的运动功能障碍、多巴胺能神经元丧失、α-突触核蛋白积累,以及黑质致密部小胶质细胞和星形胶质细胞的激活。本研究为研究PD的发病机制和治疗干预提供了一种新颖的基础研究工具。

相似文献

1
Double triggers, nasal induction of a Parkinson's disease mouse model.双重触发,帕金森病小鼠模型的鼻腔诱导。
Neurosci Lett. 2020 Apr 17;724:134869. doi: 10.1016/j.neulet.2020.134869. Epub 2020 Feb 27.
2
Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.在1-甲基-4-苯基-1,2,3,6-四氢吡啶诱导的帕金森病小鼠模型中,坍塌反应中介蛋白4的缺失可抑制多巴胺能神经元死亡。
J Neurochem. 2016 Jun;137(5):795-805. doi: 10.1111/jnc.13617. Epub 2016 Apr 12.
3
MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease.微小 RNA-124 调控 MEKK3 在帕金森病炎症发病机制中的表达。
J Neuroinflammation. 2018 Jan 12;15(1):13. doi: 10.1186/s12974-018-1053-4.
4
Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.人参皂苷 Rg1 通过靶向黑质中异常的α-突触核蛋白减轻 MPTP-丙磺舒诱导的帕金森病模型中的运动障碍和神经炎症。
Toxicol Lett. 2016 Jan 22;243:7-21. doi: 10.1016/j.toxlet.2015.12.005. Epub 2015 Dec 23.
5
Eupatilin prevents behavioral deficits and dopaminergic neuron degeneration in a Parkinson's disease mouse model.柚皮苷可预防帕金森病模型中小鼠的行为缺陷和多巴胺能神经元变性。
Life Sci. 2020 Jul 15;253:117745. doi: 10.1016/j.lfs.2020.117745. Epub 2020 May 3.
6
Temporal mRNA profiles of inflammatory mediators in the murine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrimidine model of Parkinson's disease.帕金森病小鼠1-甲基-4-苯基-1,2,3,6-四氢吡啶模型中炎症介质的瞬时mRNA谱。
Neuroscience. 2007 Mar 16;145(2):654-68. doi: 10.1016/j.neuroscience.2006.12.030. Epub 2007 Jan 29.
7
Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).胍丁胺经单次鼻腔内给予 1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)对小鼠的神经保护作用。
Behav Brain Res. 2012 Dec 1;235(2):263-72. doi: 10.1016/j.bbr.2012.08.017. Epub 2012 Aug 17.
8
Intranasal Administration of TAT-Conjugated Lipid Nanocarriers Loading GDNF for Parkinson's Disease.经鼻腔给予 TAT 缀合的载 GDNF 脂质纳米载体治疗帕金森病。
Mol Neurobiol. 2018 Jan;55(1):145-155. doi: 10.1007/s12035-017-0728-7.
9
Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease.亚急性 MPTP 处理小鼠作为帕金森病动物模型的再评估。
Acta Pharmacol Sin. 2017 Oct;38(10):1317-1328. doi: 10.1038/aps.2017.49. Epub 2017 Jun 26.
10
Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson's disease.泊洛沙姆 188 介导的抗炎作用可挽救百草枯和代森锰诱导的帕金森病小鼠模型中的认知缺陷。
Toxicology. 2020 Apr 30;436:152437. doi: 10.1016/j.tox.2020.152437. Epub 2020 Mar 10.

引用本文的文献

1
Advantages of Rho-associated kinases and their inhibitor fasudil for the treatment of neurodegenerative diseases.Rho相关激酶及其抑制剂法舒地尔在治疗神经退行性疾病方面的优势。
Neural Regen Res. 2022 Dec;17(12):2623-2631. doi: 10.4103/1673-5374.335827.
2
Lipopolysaccharide mouse models for Parkinson's disease research: a critical appraisal.用于帕金森病研究的脂多糖小鼠模型:批判性评价
Neural Regen Res. 2022 Nov;17(11):2413-2417. doi: 10.4103/1673-5374.331866.